(Q34321923)

1 August 2017

1 reference

title

Drug-resistance in human melanoma (English)

1 reference

1 August 2017

H Helmbach

1

1 reference

1 August 2017

E Rossmann

series ordinal

2

1 reference

1 August 2017

M A Kern

series ordinal

3

1 reference

1 August 2017

D Schadendorf

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

International Journal of Cancer

1 August 2017

published in

1 reference

1 August 2017

volume

93

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

617-622

1 reference

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

1 August 2017

cites work

1 reference

Desmoids in familial adenomatous polyposis are monoclonal proliferations

21 January 2018

1 reference

Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity

21 January 2018

1 reference

Biochemistry of multidrug resistance mediated by the multidrug transporter

21 January 2018

1 reference

Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance

21 January 2018

1 reference

Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells

21 January 2018

1 reference

Glutathione and related enzymes in tumor progression and metastases of human melanoma.

21 January 2018

1 reference

Altered DNA topoisomerase II in multidrug resistance

21 January 2018

1 reference

Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance

21 January 2018

1 reference

Acquisition of multiple copies of a mutant topoisomerase IIalpha allele by chromosome 17 aneuploidy is associated with etoposide resistance in human melanoma cell lines

21 January 2018

1 reference

Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance.

21 January 2018

1 reference

O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma

21 January 2018

1 reference

Apoptosis and drug response

21 January 2018

1 reference

Induction of apoptosis by cancer chemotherapy.

21 January 2018

1 reference

Apoptosis and cancer drug targeting

21 January 2018

1 reference

The central effectors of cell death in the immune system

21 January 2018

1 reference

Biochemical pathways of caspase activation during apoptosis

21 January 2018

1 reference

Two CD95 (APO-1/Fas) signaling pathways

21 January 2018

1 reference

Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3

21 January 2018

1 reference

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

21 January 2018

1 reference

An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9

21 January 2018

1 reference

DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis

21 January 2018

1 reference

Mechanisms of p53-induced apoptosis

21 January 2018

1 reference

Drug resistance in ovarian cancer - the role of p53.

21 January 2018

1 reference

Overexpression and mutations of p53 in metastatic malignant melanomas

21 January 2018

1 reference

p53-dependent apoptosis in melanoma cells after treatment with camptothecin

21 January 2018

1 reference

Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma.

21 January 2018

1 reference

Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma

21 January 2018

1 reference

Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release

21 January 2018

1 reference

Dysregulation of apoptosis in cancer

21 January 2018

1 reference

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

21 January 2018

1 reference

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

21 January 2018

1 reference

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

21 January 2018

1 reference

Association of genomic imbalances with resistance to therapeutic drugs in human melanoma cell lines

21 January 2018

1 reference

Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.1378

1 reference

1 August 2017

1 reference